<?xml version="1.0" encoding="UTF-8"?>
<p id="Par33">Second, there might be justice concerns that the data from an HCT of Disease X would not be used to generate benefits that would be valuable to those who are most affected by Disease X. For an HCT on Disease X to have sufficient social value to justify exposing individuals to risk, it is unlikely that producing a vaccine aimed at travelers rather than those in endemic regions would be sufficient to motivate the study. To the extent that the potential global social value is what justifies conducting the research, researchers and sponsors should endeavor to make the benefits of their research broadly available [
 <xref ref-type="bibr" rid="CR45">45</xref>].
</p>
